PGY1 Pharmacy Portland, Oregon

Caring for our communities for more than 75 years, Kaiser Permanente Northwest serves over 625,000 members in the Portland metro area, from Eugene, Oregon to Longview, Washington. Approximately 1020 pharmacy employees provide services in 24 pharmacy locations and 2 hospitals.

Purpose: PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

It is a 52-week, multi-site program in the Portland-metro area. The Kaiser Permanente Northwest PGY1 Residency has an ambulatory care focus and cultivates the development of leadership and clinical skills to allow residents to provide evidence-based and patient-focused care, setting them up for a career that serves to advance pharmacy practice.

---

Pharmacy Services

KPNW pharmacists work collaboratively with healthcare practitioners across the care continuum including inpatient, outpatient, transitions of care, home infusion, oncology, ambulatory care, academia, and administrative settings. With outpatient pharmacy services in nearly all of our medical offices, KPNW promotes pharmacy as an integral part of the healthcare team. KPNW pharmacists are valued and influential at every level of our organization.

KPNW is advancing the scope of pharmacy practice by developing opportunities for population management and direct patient care services in a variety of clinical specialties. With more than 50 collaborative drug therapy management protocols and authorized pharmacist prescribing, pharmacists have ample opportunity to provide direct patient care across a variety of settings

Examples of CDTMs the PGY1 Resident is involved with:
• Diabetes
• Dyslipidemia
• Hypertension
• International Travel Clinic
• Anticoagulation
• Oncology

Awards and Accomplishments

• National Committee for Quality Assurance (NCQA) rating of 4.5, 2023
• Pharmacy Quality Alliance (PQA) Excellence in Quality Award, 2022
• America’s 50 Best Hospitals, healthgrades, 2022
• J.D. Power Highest Ranking for Customer Satisfaction with Commercial Member Health Plans
• Infectious Diseases Society of America (IDSA) Antimicrobial Stewardship Center of Excellence (Sunnyside and Westside Medical Centers)
• Excellence in Stroke Care Awards, American Heart Association & American Stroke Association, 2023 (Sunnyside and Westside Medical Centers)
• Kaiser Permanente is again (fifth year in a row) one of the World’s Most Ethical Companies, according to Ethisphere, an independent group that monitors business ethics
• ASHP Residency Accreditation visit in 2018 resulted in the maximum accreditation period allowed of eight years

Portland At A Glance

---

Learning Experiences

Many of our past residents continue to serve KPNW as student and resident preceptors, which is part of the reason we place our residents’ growth and proficiency as top priorities in each learning experience we offer. We strive to create an enriching experience by offering a flexible schedule designed to drive each resident to reach their full potential.

Required Learning Experiences

• Orientation [3 weeks; Airport Way Center (AWC) Pharmacy Administration Building, NE Portland]
• Ambulatory Care I & II [4-6 weeks each; Portland metro area]
• Medication Therapy Management [4 weeks; AWC, NE Portland]
• Drug Use Management [6 weeks; AWC, NE Portland]
• Outpatient Pharmacy [2 weeks; Westside Medical Office, Hillsboro]
• Anticoagulation [4 weeks; AWC, NE Portland]
• Inpatient: Glycemic Control [4 weeks; Sunnyside Medical Center, Clackamas]
• Inpatient: Infectious Disease [4 weeks; Sunnyside Medical Center, Clackamas]
• Transitions of Care [3 weeks; AWC, NE Portland]

Required Longitudinal Learning Experiences

• Outpatient Anticoagulation Service Staffing – every other Saturday, starting in October [option for remote work]
• Pharmacy Practice and Administration
• Residency Project

Elective Learning Experiences

• Academia / Teaching Certificate with Oregon State University or Pacific University School of Pharmacy [2 weeks; Portland campus or Hillsboro campus]
• Pharmacy Administration [2-4 weeks; AWC, NE Portland]
• Clinical Informatics [4 weeks; remote]
• Ambulatory Mental Health (subject to preceptor availability) [4 weeks; Interstate Medical Office, N Portland and remote]
• Inpatient: Intensive Care Unit [4 weeks; Sunnyside Medical Center, Clackamas]
• Ambulatory Chronic Non-Malignant Pain Management [4 weeks; AWC/remote]
• Ambulatory Oncology/Hematology [4 weeks; Central Interstate Medical Office, N Portland]
• International Travel Clinic [3 weeks; AWC, NE Portland]

---

Requirements for Acceptance

• Must be licensed as an Intern Pharmacist or a Pharmacist in the state of Oregon by the first day of residency program.
• Resident must be a licensed Oregon pharmacist within 120 days from the program start date. Residents who are not licensed as a pharmacist within 120 days from the program start date will have their term of appointment extended by the number of days the resident is without licensure past the 120-day deadline up to a maximum of 45 days. Failure to obtain a Oregon state pharmacist license within 165 days from the program start date will result in the resident being dismissed from the program and employment will be terminated.
• Must be a licensed Washington Pharmacist within 180 days from the program start date.
• To be eligible for pharmacist licensure, candidates must be graduates or candidates for graduation from an ACPE accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate from the NABP.
• Certifications (If applicable): BLS
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 152313 and ASHP Program Code: 94003

---

Application Requirements

• Application process through PhORCAS
• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts sent to PhORCAS
• Three letters of references/recommendations utilizing the form in PhORCAS
• Application Deadline: January 2, 2025

---

Interview Details

• Selected applicants will be offered telephone interviews (with current residents and then with RPD) occurring in January (required for application advancement).
• Successful phone interviewees will be offered a final interview occurring in mid-February (required for application advancement).
• Click here to link to the Virtual Information Sessions:
  • November 12, 2024 – 11a.m. – 12p.m. PST
  • December 17, 2024 – 11a.m. – 12p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs